Read more
Die gründlich überarbeitete und aktualisierte 3. Auflage dieses Referenzwerks ist eine aktuelle und umfassende Handreichung für die Behandlung von Patienten mit Lebertumoren. Auch werden die einzelnen Ansätze kritisch hinterfragt. Ein neuer Abschnitt mit Richtlinien zur Behandlung von Lebertumoren spiegelt einhellige Expertenmeinungen und international geltende Leitlinien wider und hilft so Ärzten, geeignete Behandlungsmethoden für einzelne Patienten zu finden. Weitreichende und vielversprechende Entwicklungen und neue Therapienansätze aus der ganzen Welt werden in sieben Kapiteln detailliert erörtert.
List of contents
Contributors.
Preface.
Acknowledgments.
Abbreviations.
Section 1 Introduction.
1 From Promethean to Modern Times (Kuno Lehmann, Stefan Breitenstein, and Pierre-Alain Clavien).
2 Hepatic Anatomy and Terminology (Steven M. Strasberg).
Section 2 Epidemiology and Diagnosis.
Introduction (Chung-Mau Lo).
3 Histology and Pathology of Normal and Diseased Liver (Valérie Paradis and Achim Weber).
4 Pathology of Primary and Secondary Malignant Liver Tumors (Kay Washington).
5 Epidemiology, Etiology, and Natural History of Hepatocellular Carcinoma (Wei-Chen Lee and Miin-Fu Chen).
6 Epidemiology, Etiology, and Natural History of Cholangiocarcinoma (Peter Neuhaus, Ulf P. Neumann, and Daniel Seehofer).
7 Epidemiology, Etiology, and Natural History of Colorectal Liver Metastases (Robert J. Porte).
8 Tumor Markers in Primary and Secondary Liver Tumors (Ketsia B. Pierre and Ravi S. Chari).
9 Modalities for Imaging Liver Tumors (Dominik Weishaupt and Thomas F. Hany).
Section 3 Systemic and Regional Therapies.
Introduction (Ravi S. Chari).
10 Systemic Treatment of Hepatobiliary Tumors (Panagiotis Samaras, Michael A. Morse, and Bernhard C. Pestalozzi).
11 External Beam Radiation Therapy for Liver Tumors (Rakesh Reddy and A. Bapsi Chakravarthy).
12 Internal Radiation Therapy for Liver Tumors (Ahsun Riaz, Laura Kulik, Michael Abecassis, and Riad Salem).
13 Transarterial Embolization for Patients with Hepatocellular Carcinoma (Jordi Bruix, Carmen Ayuso, and Maria I. Real).
14 Selective Continuous Intra-arterial Chemotherapy for Liver Tumors (Fidel D. Huitzil-Melendez, Stefan Breitenstein, and Nancy Kemeny).
15 Isolated Hepatic Perfusion and Percutaneous Hepatic Perfusion (Charles K. Heller, III, James F. Pingpank, and Steven K. Libutti).
Section 4 Resection, Ablation or Transplantation for Liver Tumors.
Introduction (Jean-Nicolas Vauthey and Tadatoshi Takayama).
16 Liver Resection of Primary Tumors: Hepatocellular Carcinoma, Cholangiocarcinoma, and Gallbladder Cancer (Tadatoshi Takayama and Masatoshi Makuuchi).
17 Liver Resection of Colorectal Liver Metastases (Daria Zorzi, Yun Shin Chun, and Jean-Nicolas Vauthey).
18 Laparoscopic Liver Resection (Luca Viganò and Daniel Cherqui).
19 Repeat Resection for Liver Tumors (Mickael Lesurtel and Henrik Petrowsky).
20 Cryoablation of Liver Tumors (Sivakumar Gananadha and David L. Morris).
21 Thermal Ablation of Liver Tumors by Radiofrequency, Microwave, and Laser Therapy (M. B. Majella Doyle and David C. Linehan).
22 Ethanol and Other Percutaneous Injection Modalities in the Treatment of Liver Tumors (Michael A. Heneghan and Andrew D. Yeoman).
23 Transplantation for Liver Tumors (François Durand, Claire Francoz, and Jacques Belghiti).
24 Preventing Recurrence of Hepatocellular Carcinoma after Curative Resection (Stefan Breitenstein, Dimitris Dimitroulis, and Beat Müllhaupt).
Section 5 Guidelines for Liver Tumor Treatment.
Introduction (Stefan Breitenstein and Pierre-Alain Clavien).
25 Strategies for Safer Liver Surgery (Philipp Dutkowski, Olivier de Rougemont, and Pierre-Alain Clavien).
26 Hepatocellular Carcinoma (Tadatoshi Takayama).
27 Cholangiocarcinoma (Jacques Belghiti and Charles B. Rosen).
28 Gallbladder Cancer (Juan Hepp and Chung-Mau Lo).
29 Colorectal Liver Metastases (Phuong L. Doan, Jean-Nicolas Vauthey, Martin Palavecino, and Michael A. Morse).
Section 6 Emerging Therapies.
Introduction (Michael A. Morse and Josep M. Llovet).
30 Viral
About the author
Editor-in-Chief:
Pierre-Alain Clavien Department of Visceral and Transplant Surgery, University Hospital Zurich, Switzerland
Associate Editors:
Tadatoshi Takayama, Second Department of Surgery, Faculty of Medicine, University of Tokyo, Japan
CM Lo, Liver Transplant Centre, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong
R. Chari, Associate Professor of Surgery and Cancer Biology, Division Chief of Hepatobillary Surgery and Liver Transplantation, Staff Surgeon, Veterans Affairs Medical Center, Vanderbilt University Medical Center, Nashville, USA
M. Morse, Associate Professor, Duke University Medical School, Durham, USA
J. Llovet, Barcelona-Clínic Liver Cancer Group, Liver Unit, Institut d'Investigacions Biomédiques August Pi I Sunyer, Hospital Clínic, University of Barcelona, Catalonia, Spain
Summary
This comprehensive and critical review of current and established treatment modalities for malignant liver tumors is designed to help you sort through the proliferation of competitive approaches and choose the best treatment options for your patient. Dr.
Report
"This book is a worthy update. A significant amount of material has been added, including the new section. It definitely justifies replacing the old edition and will be a valuable resource for physicians of all disciplines involved in the care of these patients." ( Doody's , 23 March 2012)
"The third edition of Malignant Liver Tumors is well written with broad coverage of primary and metastatic liver tumors with a particular emphasis on current and emerging treatment. Consisting of up-to-date and comprehensive reviews on management of hepatic neoplasms, this book will not only be instructive to liver surgeons, trainees, and fellows, but also be valuable to hepatologists, oncologists, and interventional radiologists who form the multidisciplinary team to manage patients with these tumors." (Gastroenterological, 1 March 2011)
